Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.

[1]  T. Kuan.  Current studies on myofascial pain syndrome , 2009, Current pain and headache reports.

[2]  S. Onal,et al.  [Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome]. , 2009, Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology.

[3]  Roberta de Abreu Venâncio,et al.  Botulinum Toxin, Lidocaine, and Dry-Needling Injections in Patients with Myofascial Pain and Headaches , 2009, Cranio : the journal of craniomandibular practice.

[4]  B. Jabbari.  Botulinum neurotoxins in the treatment of refractory pain , 2008, Nature Clinical Practice Neurology.

[5]  L. Gerber,et al.  Assessment of myofascial trigger points (MTrPs): A new application of ultrasound imaging and vibration sonoelastography , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[6]  Y. Sertdemir,et al.  Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[7]  K. An,et al.  Identification and quantification of myofascial taut bands with magnetic resonance elastography. , 2007, Archives of physical medicine and rehabilitation.

[8]  R. Burnham,et al.  Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover study , 2005, Pain.

[9]  A. Kamanlı,et al.  Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome , 2005, Rheumatology International.

[10]  F. Ferrante,et al.  Evidence against Trigger Point Injection Technique for the Treatment of Cervicothoracic Myofascial Pain with Botulinum Toxin Type A , 2005, Anesthesiology.

[11]  R. Leuwer,et al.  [Influence of botulinum toxin on myogenous facial pain]. , 2005, Schmerz.

[12]  R. Leuwer,et al.  Beeinflussung muskulärer Gesichtsschmerzen durch Botulinumtoxin A , 2005, Der Schmerz.

[13]  L. Schmetterer,et al.  A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A , 2003, Neurology.

[14]  Amy M Lang.  A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review. , 2003, Clinical therapeutics.

[15]  K. Aoki.  Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain Management , 2003, Headache.

[16]  J. V. von Lindern,et al.  Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  M. Porta.  A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm , 2000, Pain.

[18]  Jack L. Wilson.  Travell and Simons’: Myofascial Pain and Dysfunction The Trigger Point Manual, Volume 1. Upper Half of Body, Second Edition , 1999, Regional Anesthesia & Pain Medicine.

[19]  P. Goolkasian,et al.  A Randomized, Double‐Blind, Prospective Pilot Study of Botulinum Toxin Injection for Refractory, Unilateral, Cervicothoracic, Paraspinal, Myofascial Pain Syndrome , 1998, Spine.

[20]  W. P. Cheshire,et al.  Botulinum toxin in the treatment of myofascial pain syndrome , 1994, Pain.

[21]  P. Thompson,et al.  Botulinum toxin treatment of spasmodic torticollis. , 1988, BMJ.

[22]  B. Richards,et al.  A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. , 2007, Neurology.

[23]  A. Wheeler.  Myofascial pain disorders: theory to therapy. , 2004, Drugs.

[24]  J. Travell,et al.  Myofascial Pain and Dysfunction : The Trigger Point Manual , 1982 .